Silencing survivin activates autophagy as an alternative survival pathway in HCC cells
- 393 Downloads
Autophagy is a survival mechanism that is activated in response to nutrient deprivation. The link between aberrant autophagy and cancer has been increasingly recognized. Survivin, an anti-apoptotic molecule, and the autophagy pathway are correlated with therapeutic responses to cancer. However, the role of autophagy in cancer progression remains unclear. Here, we generated survivin knockdown cells (survivin-KD) by introducing a short interfering RNA (siRNA) into hepatocellular carcinoma (HCC) cells, and we observed a 20 % reduction in the survival of these survivin-KD cells, as determined by MTT assay. In addition, an increased number of stress granules, increased positive staining by acridine orange and a shift in the high side scatter (SSC) cell population in flow cytometry analysis were observed in survivin-KD cells. Furthermore, electron microscopy revealed an increased number of autophagosomes in survivin-KD cells compared with scrambled control cells. Finally, we treated cells with an autophagy inhibitor, 3-MA, and observed a decrease in cell survival in survivin-KD cells compared with scrambled control cells. Our study suggests that an autophagy signal may be activated after the anti-apoptotic molecule survivin is suppressed. This finding implies that autophagy may be an alternative survival pathway in HCC cells and may provide a basis for the development of new therapeutic strategies for HCC.
KeywordsSurvivin Autophagy HCC Anti-proliferation
This study was supported by grants from Taipei Medical University and Shuang Ho Hospital (101TMU-SHH-9) and Ministry of Science and Technology (NSC-101-2314-B-038-016-MY3 and NSC-101-2314-B-038-029-MY3).
Conflicts of interest
- 8.A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: The cancer of the liver italian program (clip) investigators. Hepatology. 1998;28:751–5.Google Scholar
- 11.Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver cancer study group of Japan. Ann Surg. 1990;211:277–87.Google Scholar
- 34.Hou MF, Kuo HC, Li JH, Wang YS, Chang CC, Chen KC, et al. Orai1/cracm1 overexpression suppresses cell proliferation via attenuation of the store-operated calcium influx-mediated signalling pathway in a549 lung cancer cells. Biochim Biophys Acta. 1810;2011:1278–84.Google Scholar
- 36.Chang WC, Woon PY, Hsu YW, Yang S, Chiu YC, Hou MF. The association between single-nucleotide polymorphisms of orai1 gene and breast cancer in a Taiwanese population. Sci World J. 2012;2012:916587.Google Scholar